Prenatal exposure to ADHD medications, mostly methylphenidate, was not associated with an increased risk of neurodevelopmental disorders or growth restriction in exposed children.

The post Neurodevelopmental Outcomes in Infants Exposed During Pregnancy to ADHD Medications appeared first on MGH Center for Women’s Mental Health.